Cited by 191Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchRedox biology and oxidative stress

The DOI matches its Crossref record; 78 of the 79 references it cites were found in a registry or an index.

Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD

Reed, Tanea T., Pierce, William M., Markesbery, William R., Butterfield, D. Allan·2009·Brain Research

DOI 10.1016/j.brainres.2009.04.009

Open this paper in CoChat — free account

Abstract

Early Alzheimer's disease (EAD) is the intermediary stage between mild cognitive impairment (MCI) and late-stage Alzheimer's disease (AD). The symptoms of EAD mirror the disease advancement between the two phases. Dementia, memory deficits, and cognitive decline are more pronounced as the disease progresses. Oxidative stress in brain is reported in MCI and AD, including lipid peroxidation indexed by protein-bound 4-hydroxy-2-nonenal (HNE). There are limited data regarding the proteomics analysis of brain from subjects with EAD and even less concerning the possible relationship of EAD HNE-modified brain proteins with HNE-modified proteins in MCI and AD. Proteomics was utilized to investigate excessively HNE-bound brain proteins in EAD compared to those in control. These new results provide potentially valuable insight into connecting HNE-bound brain proteins in EAD to those previously identified in MCI and AD, since EAD is a transitional stage between MCI and late-stage AD. In total, six proteins were found to be excessively covalently bound by HNE in EAD inferior parietal lobule (IPL) compared to age-related control brain. These proteins play roles in antioxidant defense (manganese superoxide dismutase), neuronal communication and neurite outgrowth (dihydropyriminidase-related protein 2), and energy metabolism (alpha-enolase, malate dehydrogenase, triosephosphate isomerase, and F1 ATPase, alpha subunit). This study shows that there is an overlap of brain proteins in EAD with previously identified oxidatively modified proteins in MCI and late-stage AD. The results are consistent with the hypothesis that oxidative stress, in particular lipid peroxidation, is an early event in the progression of AD, and is the first to identify in EAD identical brain proteins previously identified as HNE-modified in MCI and late-state AD.

Integrity signals

Registry

Crossref · 10.1016/j.brainres.2009.04.009

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation
Coyle, J. T., Price, D. L., & DeLong, M. R. (1983) · Science · doi:10.1126/science.6338589 · Cited by 3,052
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury
Reaume, A. G., Elliott, J. L., Hoffman, E. K., Kowall, N. W., Ferrante, R. J., Siwek, D. F., Wilcox, H. M., Flood, D. G., Beal, M. F., Brown, R. H., et al. (1996) · Nature Genetics · doi:10.1038/ng0596-43 · Cited by 1,285
Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide
Butterfield, D. A., Drake, J., Pocernich, C., & Castegna, A. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02173-6 · Cited by 1,114
Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment
Scheff, S. W., Price, D. A., Schmitt, F. A., & Mufson, E. J. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.012 · Cited by 1,017
Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress
Butterfield, D. A., & Lauderback, C. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00794-3 · Cited by 1,013
Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction
Keller, J. N., Kindy, M. S., Holtsberg, F. W., St. Clair, D. K., Yen, H.-C., Germeyer, A., Steiner, S. M., Bruce-Keller, A. J., Hutchins, J. B., & Mattson, M. P. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-02-00687.1998 · Cited by 863
Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation
Hensley, K., Hall, N., Subramaniam, R., Cole, P., Harris, M., Aksenov, M., Aksenova, M., Gabbita, S. P., Wu, J. F., Carney, J. M., et al. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65052146.x · Cited by 779 · cited 1×
“…(indexed by free or protein-bound 4-hydroxy-2- nonenal (HNE)), and DNA and RNA oxidation (indexed by 8- hydroxy-2-deoxyguanosine and 8-hydroxyguanosine, respectively) have been reported from subjects with AD and MCI (Butterfield et al., 2006b,c, 2007; Hensley et al., 1995; Lauderback et al., 2001).”
Neuron numbers and dendritic extent in normal aging and Alzheimer’s disease
Coleman, P. D., & Flood, D. G. (1987) · Neurobiology of Aging · doi:10.1016/0197-4580(87)90127-8 · Cited by 772

Show all 79 references

Sorted by citations

Mitochondrial dysfunction and oxidative stress in aging and cancer
Kudryavtseva, A. V., Krasnov, G. S., Dmitriev, A. A., Alekseev, B. Y., Kardymon, O. L., Садритдинова, А. Ф., Fedorova, M., Pokrovsky, A. V., Melnikova, N. V., Каприн, А. Д., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9821 · Cited by 564
Amyloid β -Peptide (1–42)-Induced Oxidative Stress in Alzheimer Disease: Importance in Disease Pathogenesis and Progression
Butterfield, D. A., Swomley, A. M., & Sultana, R. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5027 · Cited by 526
Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration
Masaldan, S., Bush, A. I., Devos, D., Rolland, A., & Moreau, C. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.09.033 · Cited by 494
Pathological aspects of lipid peroxidation
Nègre‐Salvayre, A., Augè, N., Ayala, V., Başağa, H., Boada, J., Brenke, R., Chapple, S. J., Cohen, G., Fehér, J., Grune, T., et al. (2010) · Free Radical Research · doi:10.3109/10715762.2010.498478 · Cited by 465
Interaction of aldehydes derived from lipid peroxidation and membrane proteins
Pizzimenti, S., Ciamporcero, E. S., Daga, M., Pettazzoni, P., Arcaro, A., Cetrangolo, G., Minelli, R., Dianzani, C., Lepore, A., Gentile, F., et al. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00242 · Cited by 382
Lipid peroxidation and neurodegenerative disease
Reed, T. T. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.06.027 · Cited by 385
Role of Oxidative Stress in the Progression of Alzheimer's Disease
Rukhsana Sultana, A., & Butterfield, D. A. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1222 · Cited by 336
Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease
Marzia Perluigi, A., Domenico, F. D., & Butterfield, D. A. (2023) · Physiological Reviews · doi:10.1152/physrev.00030.2022 · Cited by 322
The role of lipid peroxidation in neurological disorders
Shichiri, M. (2014) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.14-10 · Cited by 282
The lipid peroxidation product 4-hydroxy-2-nonenal: Advances in chemistry and analysis
Spickett, C. M. (2013) · Redox Biology · doi:10.1016/j.redox.2013.01.007 · Cited by 269
4-Hydroxy-2-nonenal: a critical target in oxidative stress?
Breitzig, M., Bhimineni, C., Lockey, R. F., & Kolliputi, N. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00101.2016 · Cited by 284
Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders
Di Domenico, F., Tramutola, A., & Butterfield, D. A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.10.490 · Cited by 253
Self-citation
Redox Proteomics: Chemical Principles, Methodological Approaches and Biological/Biomedical Promises
Bachi, A., Dalle‐Donne, I., & Scaloni, A. (2012) · Chemical Reviews · doi:10.1021/cr300073p · Cited by 265
Elevated Oxidative Stress and Decreased Antioxidant Function in the Human Hippocampus and Frontal Cortex with Increasing Age: Implications for Neurodegeneration in Alzheimer’s Disease
Venkateshappa, C., Harish, G., Mahadevan, A., Srinivas Bharath, M. M., & Shankar, S. K. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0755-8 · Cited by 232
4-Hydroxy-nonenal—A Bioactive Lipid Peroxidation Product
Schaur, R. J., Siems, W., Bresgen, N., & Eckl, P. (2015) · Biomolecules · doi:10.3390/biom5042247 · Cited by 231
4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studies
Perluigi, M., Coccia, R., & Butterfield, D. A. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4406 · Cited by 229
Aconitase post-translational modification as a key in linkage between Krebs cycle, iron homeostasis, redox signaling, and metabolism of reactive oxygen species
Lushchak, O. V., Piroddi, M., Galli, F., & Lushchak, V. I. (2013) · Redox Report · doi:10.1179/1351000213y.0000000073 · Cited by 195
Alzheimer's Disease: Redox Dysregulation As a Common Denominator for Diverse Pathogenic Mechanisms
Rommy von Bernhardi, M., & Eugenín, J. L. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4082 · Cited by 193
Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update
Bradley‐Whitman, M. A., & Lovell, M. A. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1517-6 · Cited by 192
Abeta, oxidative stress in Alzheimer disease: Evidence based on proteomics studies
Swomley, A. M., Förster, S., Keeney, J. T. R., Triplett, J. C., Zhang, Z., Rukhsana Sultana, A., & Butterfield, D. A. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.015 · Cited by 194
Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders
Salvadores, N., Sanhueza, M., Manque, P., & Court, F. A. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00451 · Cited by 182
Trans-4-hydroxy-2-hexenal, a product of n-3 fatty acid peroxidation: Make some room HNE…
Long, E. K., & Picklo, M. J. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.03.015 · Cited by 178
Antioxidant enzymes as redox-based biomarkers: a brief review
Yang, H., & Lee, T. (2015) · BMB Reports · doi:10.5483/bmbrep.2015.48.4.274 · Cited by 181
Chemistry and analysis of HNE and other prominent carbonyl-containing lipid oxidation compounds
Sousa, B. C., Pitt, A. R., & Spickett, C. M. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.02.003 · Cited by 172
Collapsin Response Mediator Protein-2: An Emerging Pathologic Feature and Therapeutic Target for Neurodisease Indications
Hensley, K., Venkova, K. M., Christov, A., Gunning, W. T., & Park, J. C. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8166-4 · Cited by 170
Redox Proteomics in Selected Neurodegenerative Disorders: From Its Infancy to Future Applications
Butterfield, D. A., Marzia Perluigi, A., Reed, T. T., Muharib, T., Hughes, C. P., Robinson, R. A. S., & Rukhsana Sultana, A. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4109 · Cited by 171
Role of By-Products of Lipid Oxidation in Alzheimer's Disease Brain: A Focus on Acrolein
Singh, M., Nam, D. T., Arseneault, M., & Ramassamy, C. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100405 · Cited by 162
Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrain
Gururaj Joshi, A., Aluise, C. D., Cole, M. P., Rukhsana Sultana, A., Pierce, W. M. J., Vore, M. E., Clair, D. K. S., & Butterfield, D. A. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.01.021 · Cited by 159
Oxidative stress and lipid peroxidation are upstream of amyloid pathology
Arimon, M., Takeda, S., Post, K. E., Svirsky, S. E., Hyman, B. T., & Berezovska, O. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.06.013 · Cited by 157
Advances in methods for the determination of biologically relevant lipid peroxidation products
Spickett, C. M., Wiswedel, I., Siems, W., Žarković, K., & Žarković, N. (2010) · Free Radical Research · doi:10.3109/10715762.2010.498476 · Cited by 156
Protein carbonylation and metabolic control systems
Curtis, J. M., Hahn, W. S., Long, E. K., Burrill, J. S., Arriaga, E. A., & Bernlohr, D. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.05.008 · Cited by 164
Triosephosphate isomerase deficiency: New insights into an enigmatic disease
Orosz, F., Oláh, J., & Ovádi, J. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.09.012 · Cited by 152
Insights into the Pathogenesis of Neurodegenerative Diseases: Focus on Mitochondrial Dysfunction and Oxidative Stress
Jurcău, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111847 · Cited by 152
Connecting the “Dots”: From Free Radical Lipid Autoxidation to Cell Pathology and Disease
Foret, M. K., Lincoln, R., Carmo, S. D., Cuello, A. C., & Cosa, G. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00761 · Cited by 150
CuII(atsm) inhibits ferroptosis: Implications for treatment of neurodegenerative disease
Southon, A. G., Szostak, K., Acevedo, K. M., Dent, K. A., Volitakis, I., Belaidi, A. A., Barnham, K. J., Crouch, P. J., Ayton, S., Donnelly, P. S., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14881 · Cited by 143
DNA polymerase β deficiency leads to neurodegeneration and exacerbates Alzheimer disease phenotypes
Sýkora, P., Misiak, M., Wang, Y., Ghosh, S., Leandro, G. D. S., Liu, D., Tian, J. Y., Baptiste, B. A., Cong, W., Brenerman, B. M., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1356 · Cited by 140
CMS121, a fatty acid synthase inhibitor, protects against excess lipid peroxidation and inflammation and alleviates cognitive loss in a transgenic mouse model of Alzheimer's disease
Ates, G., Goldberg, J., Currais, A. J. M., & Maher, P. A. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101648 · Cited by 131
The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: It's time for reconciliation
Barone, E., Di Domenico, F., Mancuso, C., & Butterfield, D. A. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.09.018 · Cited by 127
Self-citation
Exploring the Biology of Lipid Peroxidation-Derived Protein Carbonylation
Fritz, K. S., & Petersen, D. R. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200169n · Cited by 129
The 2013 SFRBM Discovery Award: Selected discoveries from the Butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment
Butterfield, D. A. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.006 · Cited by 126
Differences in Susceptibility to Inactivation of Human Aldehyde Dehydrogenases by Lipid Peroxidation Byproducts
Yoval‐Sánchez, B., & Rodríguez‐Zavala, J. S. (2012) · Chemical Research in Toxicology · doi:10.1021/tx2005184 · Cited by 125
Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer's disease
Chou, J. L., Shenoy, D. V., Thomas, N., Choudhary, P. K., LaFerla, F. M., Goodman, S. R., & Breen, G. A. M. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2010.12.012 · Cited by 123
A Reversible Early Oxidized Redox State That Precedes Macromolecular ROS Damage in Aging Nontransgenic and 3xTg-AD Mouse Neurons
Ghosh, D., LeVault, K. R., Barnett, A., & Brewer, G. J. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6192-11.2012 · Cited by 124
Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease
Butterfield, D. A., Reed, T. T., & Rukhsana Sultana, A. (2010) · Free Radical Research · doi:10.3109/10715762.2010.520014 · Cited by 125
Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?
Moya‐Alvarado, G., Gershoni‐Emek, N., Perlson, E., & Bronfman, F. C. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r115.053330 · Cited by 124
The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics
Di Domenico, F., Barone, E., Perluigi, M., & Butterfield, D. A. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6759 · Cited by 114
Mass spectrometry and redox proteomics: Applications in disease
Butterfield, D. A., Gu, L., Domenico, F. D., & Robinson, R. A. S. (2013) · Mass Spectrometry Reviews · doi:10.1002/mas.21374 · Cited by 113
Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain
Butterfield, D. A., Domenico, F. D., Swomley, A. M., Head, E., & Marzia Perluigi, A. (2014) · Biochemical Journal · doi:10.1042/bj20140772 · Cited by 112
Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer’s disease
Lassmann, H. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0607-8 · Cited by 112
Redox proteomics and amyloid β-peptide: Insights into Alzheimer disease
Butterfield, D. A., & Boyd‐Kimball, D. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14589 · Cited by 105
Self-citation
Impaired mitochondrial energy metabolism in Alzheimer's disease: Impact on pathogenesis via disturbed epigenetic regulation of chromatin landscape
Salminen, A., Haapasalo, A., Kauppinen, A., Kaarniranta, K., Soininen, H. S., & Hiltunen, M. O. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.05.001 · Cited by 107
Vascular and metabolic dysfunction in Alzheimer’s disease: a review
Murray, I. V. J., Proza, J. F., Sohrabji, F., & Lawler, J. M. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.010355 · Cited by 104
Strategy to reduce free radical species in Alzheimer’s disease: an update of selected antioxidants
Domenico, F. D., Barone, E., Marzia Perluigi, A., & Butterfield, D. A. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.955853 · Cited by 103
Redox active metals in neurodegenerative diseases
Acevedo, K. M., Masaldan, S., Opazo, C., & Bush, A. I. (2019) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-019-01731-9 · Cited by 102
Interactions of glutathione transferases with 4-hydroxynonenal
Balogh, L. M., & Atkins, W. M. (2011) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.558092 · Cited by 105
Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease
Domenico, F. D., Pupo, G., Tramutola, A., Giorgi, A., Schininà, M. E., Coccia, R., Head, E., Butterfield, D. A., & Marzia Perluigi, A. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.03.027 · Cited by 98
Mitochondrial Dysfunction in Cancer and Neurodegenerative Diseases: Spotlight on Fatty Acid Oxidation and Lipoperoxidation Products
Barrera, G., Gentile, F., Pizzimenti, S., Canuto, R. A., Daga, M., Arcaro, A., Cetrangolo, G. P., Lepore, A., Ferretti, C., Dianzani, C., et al. (2016) · Antioxidants · doi:10.3390/antiox5010007 · Cited by 98
Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer’s disease: Insights into memory loss in MCI
Aluise, C. D., Robinson, R. A. S., Cai, J., Pierce, W. M., Markesbery, W. R., & Butterfield, D. A. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101083 · Cited by 94
Self-citation
Brain lipid peroxidation and alzheimer disease: Synergy between the Butterfield and Mattson laboratories
Butterfield, D. A. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101049 · Cited by 98
Regulation of autophagy, mitochondrial dynamics, and cellular bioenergetics by 4-hydroxynonenal in primary neurons
Dodson, M. B., Wani, W. Y., Redmann, M., Benavides, G. A., Johnson, M. S., Ouyang, X., Cofield, S. S., Mitra, K., Darley-Usmar, V. M., & Zhang, J. (2017) · Autophagy · doi:10.1080/15548627.2017.1356948 · Cited by 93
Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease
Butterfield, D. A., & Boyd-Kimball, D. (2020) · Antioxidants · doi:10.3390/antiox9090818 · Cited by 85
“MnSOD is oxidatively modified by HNE in early AD IPL, resulting in a significant decrease in enzyme activity [55] and is also oxidatively modified by HNE in late AD IPL [54].”
BackgroundInfluential
Characterization of Aldh2 -/- mice as an age-related model of cognitive impairment and Alzheimer’s disease
D’Souza, Y., Elharram, A., Soon-Shiong, R., Andrew, R. D., & Bennett, B. M. (2015) · Molecular Brain · doi:10.1186/s13041-015-0117-y · Cited by 87
An update on clinical proteomics in Alzheimer’s research
Korolainen, M. A., Nyman, T. A., Aittokallio, T. A., & Pirttilä, T. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06558.x · Cited by 88
The calcium–iron connection in ferroptosis-mediated neuronal death
Gleitze, S., Paula-Lima, A. C., Núñez, M. T., & Hidalgo, C. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.08.231 · Cited by 84
Quantitative susceptibility mapping as an imaging biomarker for Alzheimer’s disease: The expectations and limitations
Uchida, Y., Kan, H., Sakurai, K., Oishi, K., & Matsukawa, N. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.938092 · Cited by 88
Mitochondrial lipids in neurodegeneration
Aufschnaiter, A., Kohler, V., Diessl, J., Peselj, C., Carmona‐Gutiérrez, D., Keller, W., & Büttner, S. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2463-1 · Cited by 91
Lipids and lipoxidation in human brain aging. Mitochondrial ATP-synthase as a key lipoxidation target
Jové, M., Pradas, I., Domínguez-González, M., Ferrer, I., & Pamplona, R. (2018) · Redox Biology · doi:10.1016/j.redox.2018.101082 · Cited by 84
Intake of ω-6 Polyunsaturated Fatty Acid-Rich Vegetable Oils and Risk of Lifestyle Diseases
Yamashima, T., Ota, T., Mizukoshi, E., Nakamura, H., Yamamoto, Y., Kikuchi, M., Yamashita, T., & Kaneko, S. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa072 · Cited by 78
Proteomic Identification of Binding Partners for the Brain Metabolite Lanthionine Ketimine (LK) and Documentation of LK Effects on Microglia and Motoneuron Cell Cultures
Hensley, K., Christov, A., Kamat, S., Zhang, X. C., Jackson, K. W., Snow, S., & Post, J. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5247-09.2010 · Cited by 78
Collapsin Response Mediator Protein-2 (CRMP2) is a Plausible Etiological Factor and Potential Therapeutic Target in Alzheimer’s Disease: Comparison and Contrast with Microtubule-Associated Protein Tau
Hensley, K., & Kursula, P. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160076 · Cited by 72
Synaptic Mitochondria are More Susceptible to Traumatic Brain Injury-induced Oxidative Damage and Respiratory Dysfunction than Non-synaptic Mitochondria
Hill, R. L., Kulbe, J. R., Singh, I. N., Wang, J. A., & Hall, E. D. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.06.028 · Cited by 75
Functionalized nanosystems for targeted mitochondrial delivery
Durazo, S. A., & Kompella, U. B. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.11.001 · Cited by 73
Deuterium‐reinforced polyunsaturated fatty acids improve cognition in a mouse model of sporadic Alzheimer's disease
Elharram, A., Czegledy, N. M., Golod, M., Milne, G. L., Pollock, E. D., Bennett, B. M., & Shchepinov, M. S. (2017) · FEBS Journal · doi:10.1111/febs.14291 · Cited by 74
Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives
Lanzillotta, C., Domenico, F. D., Marzia Perluigi, A., & Butterfield, D. A. (2019) · CNS Drugs · doi:10.1007/s40263-019-00658-8 · Cited by 75
Ginsenoside Rg3 Prevents Cognitive Impairment by Improving Mitochondrial Dysfunction in the Rat Model of Alzheimer’s Disease
Zhang, Y., Yang, X., Wang, S., & Song, S. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b03793 · Cited by 70
Glutathione: An Old and Small Molecule with Great Functions and New Applications in the Brain and in Alzheimer's Disease
Haddad, M., Hervé, V., Ben Khedher, M. R., Rabanel, J.-M., & Ramassamy, C. (2021) · Antioxidants & Redox Signaling · doi:10.1089/ars.2020.8129 · Cited by 68
Targeting Glycogen Synthase Kinase‐3β for Therapeutic Benefit against Oxidative Stress in Alzheimer′s Disease: Involvement of the Nrf2‐ARE Pathway
Kanninen, K. M., White, A. R., Koıstınaho, J., & Malm, T. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/985085 · Cited by 70
Inflammatory Markers in Mild Cognitive Impairment: A Meta-Analysis
Saleem, M., Herrmann, N., Swardfager, W., Eisen, R. B., & Lanctôt, K. L. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150042 · Cited by 64
Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease
Rahmadi, A., Steiner, N., & Münch, G. W. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.079 · Cited by 63
Lipocalin 2 regulates iron homeostasis, neuroinflammation, and insulin resistance in the brains of patients with dementia: Evidence from the current literature
Lim, D., Jeong, J., & Song, J. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13653 · Cited by 64
Early Induction of Oxidative Stress in Mouse Model of Alzheimer Disease with Reduced Mitochondrial Superoxide Dismutase Activity
Lee, H. P., Pancholi, N., Esposito, L., Previll, L. A., Wang, X., Zhu, X., Smith, M. A., & Lee, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028033 · Cited by 61
Metabolic control of signalling pathways and metabolic auto‐regulation
Lorendeau, D., Christen, S., Rinaldi, G., & Fendt, S. (2015) · Biology of the Cell · doi:10.1111/boc.201500015 · Cited by 60
Evidence in Support of Potential Applications of Lipid Peroxidation Products in Cancer Treatment
Erejuwa, O. O., Sulaiman, S. A., & Wahab, M. S. A. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/931251 · Cited by 58
The Role of Mitochondrial Aldehyde Dehydrogenase 2 (ALDH2) in Neuropathology and Neurodegeneration.
Chen, C., Joshi, A. U., & Mochly‐Rosen, D. (2016) · PubMed · Cited by 58
Ginsenosides in central nervous system diseases: Pharmacological actions, mechanisms, and therapeutics
Lu, J., Wang, X., Wu, A., Cao, Y. L., Dai, X., Liang, Y., & Li, X. (2022) · Phytotherapy Research · doi:10.1002/ptr.7395 · Cited by 59
Cell Cycle Proteins in Brain in Mild Cognitive Impairment: Insights into Progression to Alzheimer Disease
Keeney, J. T. R., Swomley, A. M., Harris, J. L., Fiorini, A., Mitov, M. I., Marzia Perluigi, A., Rukhsana Sultana, A., & Butterfield, D. A. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9287-2 · Cited by 56
Inhibition of glycolysis attenuates 4-hydroxynonenal-dependent autophagy and exacerbates apoptosis in differentiated SH-SY5Y neuroblastoma cells
Dodson, M. B., Liang, Q., Johnson, M. S., Redmann, M., Fineberg, N. S., Darley-Usmar, V. M., & Zhang, J. (2013) · Autophagy · doi:10.4161/auto.26094 · Cited by 57
Mitochondrial ATP Synthase is a Target of Oxidative Stress in Neurodegenerative Diseases
Ebanks, B., & Chakrabarti, L. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.854321 · Cited by 57
Lipophilic antioxidants in neurodegenerative diseases
Chang, K., Cheng, M., Chiang, M.-C., & Chen, C. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.06.031 · Cited by 59
HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology
Barone, E., Head, E., Butterfield, D. A., & Perluigi, M. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.10.508 · Cited by 53
Hypoxia and GABA shunt activation in the pathogenesis of Alzheimer's disease
Salminen, A., Jouhten, P., Sarajärvi, T., Haapasalo, A., & Hiltunen, M. O. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.11.005 · Cited by 56
The synaptic proteome in Alzheimer's disease
Chang, R. Y. K., Nouwens, A. S., Dodd, P. R., & Etheridge, N. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.04.009 · Cited by 52
Presymptomatic Alterations in Energy Metabolism and Oxidative Stress in the APP23 Mouse Model of Alzheimer Disease
Hartl, D., Schuldt, V., Forler, S., Zabel, C., Klose, J., & Rohe, M. (2012) · Journal of Proteome Research · doi:10.1021/pr300021e · Cited by 48
Protein adducts of malondialdehyde and 4-hydroxynonenal contribute to trichloroethene-mediated autoimmunity via activating Th17 cells: Dose– and time–response studies in female MRL+/+ mice
Wang, G., Wang, J., Fan, X., Ansari, G. A. S., & Khan, M. F. (2011) · Toxicology · doi:10.1016/j.tox.2011.12.001 · Cited by 47
Elevated Protein Carbonylation, and Misfolding in Sciatic Nerve from db/db and Sod1−/− Mice: Plausible Link between Oxidative Stress and Demyelination
Hamilton, R. T., Bhattacharya, A., Walsh, M. E., Shi, Y., Wei, R., Zhang, Y., Rodriguez, K. A., Buffenstein, R., Chaudhuri, A. R., & Remmen, H. V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065725 · Cited by 48
Reductive stress in young healthy individuals at risk of Alzheimer disease
Badía, M.-C., Giraldo, E., Dası́, F., Alonso, D., Lainez, J. M., Lloret, A., & Viña, J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.003 · Cited by 48
Mitochondrial function in human brains is affected by pre‐ and post mortem factors
Harish, G., Venkateshappa, C., Mahadevan, A., Pruthi, N., Bharath, M. M. S., & Shankar, S. K. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2012.01285.x · Cited by 45
A Derivative of the Brain Metabolite Lanthionine Ketimine Improves Cognition and Diminishes Pathology in the 3×Tg-AD Mouse Model of Alzheimer Disease
Hensley, K., Gabbita, S. P., Venkova, K. M., Hristov, A. M., Johnson, M. F., Eslami, P., & Harris‐White, M. E. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182a74372 · Cited by 44
The role of ferroptosis in neurodegenerative diseases
Xu, Y., Zhao, J., Zhao, Y., Zhou, L., Qiao, H., Xu, Q., & Liu, Y. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-08048-y · Cited by 43
Plant polyphenols in the treatment of age‐associated diseases: Revealing the pleiotropic effects of icariin by network analysis
Schluesener, J. K., & Schluesener, H. J. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300409 · Cited by 39

Authors: Reed, T. T., Pierce, W. M., Markesbery, W. R., & Butterfield, D. A.
Affiliations: University of Kentucky (US)
University of Louisville (US)
Corresponding author: Butterfield, D. Allan
ORCID: Reed, Tanea T.
Butterfield, D. Allan
Venue: Brain Research
Publisher: Elsevier BV
Published: 2009-06
Volume: 1274
Pages: 66-76
ISSN: 0006-8993 (ISSN-L)
DOI: 10.1016/j.brainres.2009.04.009
OpenAlex: W2076534507
Cited by: 190
References: 79
Citations by year: 2026: 3 · 2025: 2 · 2024: 1 · 2023: 8 · 2022: 7 · 2021: 13 · 2020: 12 · 2019: 9 · 2018: 11 · 2017: 8 · 2016: 14 · 2015: 13 · 2014: 14 · 2013: 16 · 2012: 16
FWCI: 13.03
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Brain Research (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Aging (AG-0288383, P01AG010836, P01AG005119, AG 10836, AG0 5119)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
Keywords: early Alzheimer's disease, 4-hydroxynonenal, lipid peroxidation, oxidative stress, protein oxidation, brain proteomics, inferior parietal lobule, manganese superoxide dismutase, alpha-enolase, malate dehydrogenase, triosephosphate isomerase, F1-ATPase, antioxidant defense, energy metabolism, neural communication, disease progression
MeSH terms: Aged, Aged, 80 and over, Aldehydes, Alzheimer Disease, Brain, Female, Humans, Male, Proteins, Blotting, Western, Lipid Peroxidation, Oxidative Stress, Disease Progression, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Proteomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks